Antibody Information
General Information of This Antibody
Antibody ID | ANI0EIQGP |
|||||
---|---|---|---|---|---|---|
Antibody Name | B12 |
|||||
Antibody Type | Monoclonal antibody (mAb) |
|||||
Antibody Subtype | Humanized IgG1-kappa |
|||||
Antigen Name | Envelope glycoprotein gp160 (env) |
Antigen Info |
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
B12-PEG-G5-DOX [Investigative]
Discovered Using Cell Line-derived Xenograft Model
Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Tumor Growth Inhibition value (TGI) | ≈ 56.39% (Day 84) | |||
Method Description |
The OVCAR-3 ovarian cancer cell line was mixed with matrigel and injected subcutaneously into Athymic nude immunodeficient mouse to observe tumor growth. After 77 days of tumor growth, treatment with the antibody (B12 antibody) and B12-Dendrimer Conjugates was initiated Nine doses were administered intraperitoneally three times a week.
|
||||
In Vivo Model | OVCAR-3 CDX model | ||||
In Vitro Model | Ovarian serous adenocarcinoma | OVCAR-3 cells | CVCL_0465 |
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.